Skip to main content
. 2020 Aug 23;8(3):471. doi: 10.3390/vaccines8030471

Table 3.

Characteristics of study participants associated with SARS-CoV-2 swab positive results (vs. negative results).

All <65 Years ≥65 Years
OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value
(a) Not adjusted model
Flu shot during last autumn 1.02 0.91–1.15 0.7387 0.86 0.750.99 0.0301 0.83 0.601.14 0.2440
Anti-pneumococcal vaccination 0.77 0.58–1.02 0.0635 0.67 0.460.97 0.0342 0.42 0.260.66 0.0002
(b) Adjusted model *
Flu shot during last autumn 0.89 0.78–1.01 0.1408 0.85 0.740.98 0.0235 0.87 0.591.28 0.4826
Anti-pneumococcal vaccination 0.56 0.41–0.75 0.0001 0.61 0.410.91 0.0156 0.56 0.330.95 0.0313

* adjusted for sex (males vs. females), age (years, continuous for “all model”; dichotomized into <67 vs. ≥67 for “≥65 years model”; dichotomized into ≥54 vs. <54 for “<65 years model”), education (high school diploma, university degree or post-graduate degree vs. middle school, primary school or less), Italian area of residence (area 1 vs. (3,4); area 2 vs. (3,4)), dichotomized self-reported diseases (CVD, hypertension, lung diseases, diabetes treated with medications, metabolic diseases), smoking status (current smoker vs. never smoker or former smoker) and contact with confirmed COVID-19 cases (yes vs. no).